NWA Oncologist Collaborates on Research of Non-Hodgkin's Lymphoma
Highlands Oncology Group Physician Collaborated On Research To Be Published
Rogers, AR, May 9, 2016 (Newswire.com) - Dr. J Thaddeus Beck, of Highlands Oncology Group (Highlands), Northwest Arkansas’ premier cancer treatment facility, collaborated on research of non-Hodgkin’s lymphoma which has been accepted for publication. The research will be published in the medical journal, Future Oncology.
The research, entitled “Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin’s lymphoma” studies the effectiveness of a specifically targeted treatment of non-Hodgkin’s lymphoma.
Non-Hodgkin’s lymphoma is a dangerous and pervasive disease in the United States, and globally. As such, continuous research is necessary for advancement in treatment options. The disease accounts for about four percent of all cancer cases in the U.S., according to the American Cancer Society.
Approximately 2.1 percent of men and women will be diagnosed with non-Hodgkin’s lymphoma at some point during their lifetime, based on 2010-2012 data, according to the National Cancer Institute (NCI). In 2013, there were an estimated 569,536 people living with non-Hodgkin lymphoma in the United States, according to the NCI.
Future Oncology provides a forum for a new era of cancer care, according to the journal’s website.The journal focuses on the most important advances in the field of oncology and highlights their relevance in the clinical setting.
As the leading cancer treatment and research facility in Northwest Arkansas, Highlands is dedicated to the advancement of cancer treatment and to providing patients with the best possible care and results.
Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.
For more information visit www.HighlandsOncologyGroup.com.
Source: Highlands Oncology Group